Botulinum toxin type A clinical trials
Also written Botox, OnabotulinumtoxinA, Xeomin and NT 201.
Includes 109 studies of Onabotulinum toxin A, 19 studies of incobotulinumtoxinA and 18 studies of Prabotulinumtoxin A.
How each study uses botulinum toxin type A is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the botulinum toxin type A studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 9 Dec 1991 · BOTOX COSMETIC · BLA 103000 (FDA, Drugs@FDA)
- European Union
- 27 Sept 2019 · Nuceiva · EMEA/H/C/004587 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Name
Studies by the year they started
814 studies that test it; most in 2012 (48); 4 more planned to start later
| Year | Studies |
|---|---|
| 1997 | 2 |
| 1999 | 1 |
| 2000 | 1 |
| 2002 | 5 |
| 2003 | 16 |
| 2004 | 11 |
| 2005 | 25 |
| 2006 | 21 |
| 2007 | 33 |
| 2008 | 17 |
| 2009 | 35 |
| 2010 | 28 |
| 2011 | 45 |
| 2012 | 48 |
| 2013 | 40 |
| 2014 | 46 |
| 2015 | 37 |
| 2016 | 43 |
| 2017 | 28 |
| 2018 | 42 |
| 2019 | 42 |
| 2020 | 29 |
| 2021 | 43 |
| 2022 | 38 |
| 2023 | 37 |
| 2024 | 38 |
| 2025 | 28 |
| 2026 | 35 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 303 · Other 517
Allergan (76) · Ipsen (44) · Merz Pharmaceuticals GmbH (31) · Medy-Tox (23) · AbbVie (22) · Revance Therapeutics, Inc. (20) · Cairo University (12) · Galderma R&D (11)
Often tested with
Tested in the same studies.
Sodium Chloride (4) · Saline Solution (3) · abobotulinumtoxinA (3) · Lidocaine (3) · Baclofen (2) · rimabotulinumtoxinB (2) · Oxybutynin (2) · Hyaluronic Acid (2)
Related medicines
As reviewed, each with the page that says it.
- One of Botulinum Toxins source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Tested against it · 5 phase 3 studies under way
Botulinum toxin type A is the comparator. A study of two new drugs counts under both.
- 2HU-045 · Huons Biopharma · next primary completion May 2027
- 1EP4 Receptor Antagonist YY001 · Chongqing Claruvis Pharmaceutical Co., Ltd.
Reaching primary completion within a year · 34, 8 in phase 3
Studies that test botulinum toxin type A, phase 3 first.
- Dec 2026Comparative Study of the Effects of Dry Needling and Botulinum Toxin Type A as a Treatment for Lower Limb Post-stroke SpasticityPhase 2/3 · Universiteit Antwerpen
- Feb 2027BOTOX® vs. XEOMIN® for Chronic MigrainePhase 3 · Naval Medical Center Camp Lejeune
- Mar 2027A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic MigrainePhase 3 · Merz Therapeutics GmbH
- Mar 2027A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Chronic MigrainePhase 3 · Merz Therapeutics GmbH
- May 2027Efficacy of Two Ultrasound-guided Intra-articular Injections of Botox® Combined With Custom-made Rigid Splinting in Painful Base-of-thumb Osteoarthritis.Phase 2/3 · Assistance Publique - Hôpitaux de Paris
- May 2027Evaluation of the Efficacy and Safety of Fractional CO₂ Laser With and Without Intradermal Botulinum Toxin A in the Treatment of Inflammatory Facial Acne Vulgaris.Phase 3 · Cairo University
- Jun 2027Effectiveness and Safety of Early Intramuscular Botulinum Toxin Injections to Prevent Shoulder Deformity in Babies With Obstetrical Brachial Plexus PalsyPhase 3 · University Hospital, Brest
- Aug 2027Onabotulinum Toxin A (Botox) in the Treatment of Pharyngo-esophageal DysphagiaPhase 2/3 · All India Institute of Medical Sciences
- Dec 2026Botulinum Toxin A Versus Steroids for the Treatment of Chronic Plantar FasciitisNot applicable · Insel Gruppe AG, University Hospital Bern
- Dec 2026Intraarticular Injection of Botox and Hyaluronic Acid in Knee OsteoarthritisNot applicable · Tanta University
Studies
Open first, then newest update. How each study uses botulinum toxin type A is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 820
- EndoFLIP-Guided Initial Management of Esophagogastric Junction Outflow ObstructionNot yet recruitingNot applicableHospital Clinic of BarcelonaNCT07930143Written as Botulinum Toxin Type A (BOTOX) Injection
- Evaluation of the Efficacy and Safety of Fractional CO₂ Laser With and Without Intradermal Botulinum Toxin A in the Treatment of Inflammatory Facial Acne Vulgaris.Not yet recruitingPhase 3Cairo UniversityNCT07919886Written as Botulinium Toxin-A
- Early Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and IndependenceNot yet recruitingEarly Phase 1Instituto Mexicano del Seguro SocialNCT06811142Written as Botulinum Toxin Type A (BoNT-A)
- Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Essential TremorRecruitingPhase 2AbbVieNCT07673107Written as AGN-151607-DP
- Xeomin® and Gait Related Mobility After StrokeRecruitingPhase 4Wake Forest University Health SciencesNCT04908423Written as Xeomin®
- Preoperative BOTOX® Injection for Large Ventral Hernia RepairRecruitingPhase 4The Cleveland ClinicNCT07220382Written as OnabotulinumtoxinA
- Efficacy of Botulinum Toxin Versus Placebo on Pain and Health Related Quality of Life of Patients With Piriformis Muscle SyndromeNot yet recruitingPhase 2Centre Hospitalier Universitaire de NīmesNCT07624045Written as Botulinum Toxin - A injections
- Perineural Botulinum Toxin Injection Versus Oral Duloxetine in Relief of Foot Pain in Painful Peripheral Diabetic NeuropathyNot yet recruitingPhase 2Assiut UniversityNCT07882238Written as Botulinum Toxin Type A
- Cleft Lip Scarring After BotoxRecruitingPhase 2Children's National Research InstituteNCT07880860Written as Botulinum Toxin Type A (BOTOX) Injection
- MRI Study of OnabotulinumtoxinA (OnabotA) Effect on Jaw Muscle PainNot yet recruitingPhase 2Weill Medical College of Cornell UniversityNCT07878780Written as Onabotulinumtoxin A
- Botulinum Toxin Type A Versus Triamcinolone for Facial MyalgiaNot yet recruitingPhase 4Riyadh Elm UniversityNCT07867379Written as Botulinum Toxin A (Botox )
- Study to Assess Participant Satisfaction After Jawline and Neck TreatmentRecruitingPhase 4AbbVieNCT07794891Written as OnabotulinumtoxinA
- Efficacy of Botulinum Toxin A Versus Nanofat in the Treatment of Androgenetic Alopecia: A Comparative Clinical TrialNot yet recruitingPhase 2/3Sherief Ayman Hussein ShaamashNCT07863856Written as Botulinum Toxin Type A
- Botulinum Toxin-A for Bruxism Using Digital Occlusal AnalysisNot yet recruitingEarly Phase 1Bilecik Seyh Edebali UniversitesiNCT07640035Written as Botulinum Toxin-A injection
- DaxibotulinumtoxinA for BlepharospasmRecruitingPhase 2University of PennsylvaniaNCT07489430Written as Botulinum Neurotoxin Type A
- Clinical Evaluation of Botulinum Toxin a in the Management of Temporomandibular Myofascial PainRecruitingPhase 2Riphah International UniversityNCT07847541Written as Botulinum Toxin Type A (BoNT-A)
- Comparison of the Effectiveness of Greater Occipital Nerve and Supratrochlear Nerve Pulsed Radiofrequency Versus Botulinum Toxin Type A Injection in Chronic MigraineNot yet recruitingPhase 4Assiut UniversityNCT07837570Written as OnabotulinumtoxinA
- Effectiveness of Greater Occipital Nerve and Supratrochlear Nerve Pulsed Radiofrequency Versus Botulinum Toxin Type A Injection in Chronic MigraineNot yet recruitingPhase 4Assiut UniversityNCT07780136Written as OnabotulinumtoxinA
- Botulinum Toxin Blockade of Neuronal Signals to Immune Cells as a Novel Treatment for Hidradenitis SuppurativaNot yet recruitingPhase 2University of Massachusetts, WorcesterNCT07756346Written as Botulinum Toxin A (Allergan, Inc, Irvine CA)
- Early BOTOX After Spinal Cord InjuryEnrolling by invitationEarly Phase 1University of WashingtonNCT06793683Written as Bladder chemodenervation (Botox)
See all 820 studies that test botulinum toxin type A →
Given beside what is tested · 36 — botulinum toxin type A is usual care or a partner of the new treatment
- Efficacy of Intracavernosal Xeomin With Tadalafil for Mild-Moderate Erectile DysfunctionNot yet recruitingPhase 2Northwestern UniversityNCT07537855Written as IncobotulinumtoxinA (100 Units)
- A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Upper Limb Spasticity.RecruitingPhase 1/2IpsenNCT04752774Written as Dysport
- Efficacy of Extracorporeal Shock Wave Therapy in Children With Cerebral PalsyNot yet recruitingPhase 3Kocaeli UniversityNCT06128616Written as Botulinum Toxin Type A
- A Study to Evaluate Sequential Administration of Injections of AGN-151586 Followed by BOTOX in Adult Participants for Treatment of Glabellar LinesActive, not recruitingPhase 1AbbVieNCT07756580Written as BOTOX
- Botox or Botox With Esophageal Dilation in Patients With AchalasiaCompletedPhase 4Vanderbilt University Medical CenterNCT03654066Written as Botulinum toxin type A
- Efficacy of Focused Shock Wave Therapy Before and After Botulinum Toxin Injection in Patients With Post-Stroke Spastic Equinus/Equinovarus Foot: A Randomized Clinical TrialActive, not recruitingNot applicableMaría Belén Martínez LunaNCT07758322Written as Botulinum toxin type A
- Zinc Supplementation Prior to Botox Injections for Spasmodic DysphoniaCompletedPhase 1/2University of FloridaNCT05892770Written as Botulinum toxin type A
- A Study to Evaluate Sequential Administration of AGN-151586 and OnabotulinumtoxinA (BOTOX) Injections in Adult Participants for Treatment of Glabellar LinesCompletedPhase 1AbbVieNCT05496335Written as BOTOX
- BTX-A and Mirror Therapy for Chronic Stroke SpasticityCompletedNot applicableFatih Sultan Mehmet Training and Research HospitalNCT07331844Written as Botulinum toxin type A (Botox®, Allergan)
- A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)CompletedPhase 1AbbVieNCT06834789Written as OnabotulinumtoxinA
- Effects of EMG-driven Robot-assisted Therapy for the Distal Upper Limb Motor Function in the Chronic Stroke Patients With Botox InjectionsCompletedPhase 2Cheng-Hsin General HospitalNCT04502264Written as Botulinum toxin type A injection
- Efficacy of Extracorporeal Shock Wave Therapy on SpasticityCompletedNot applicableKayseri City HospitalNCT06225024Written as BoNT A
- A Study to Evaluate Participant Satisfaction With Facial Appearance Overall and the Aesthetic and Psychosocial Impact of Combined Facial TreatmentCompletedPhase 4AllerganNCT03712449Written as BOTOX Cosmetic®
- Botulinum Toxin A & Weekly Serial Casting in ABI Inpatients With Lower Extremity SpasticityWithdrawnPhase 2Hamilton Health Sciences CorporationNCT03903653Written as Botulinum toxin type A
- Neurotoxin and Physical TherapyCompletedPhase 4University of FloridaNCT02177617Written as Botox injection
- The Effect of Botulinum Toxin A In Patients With Excessive Gingival Display With And Without Zinc SupplementationCompletedPhase 3Cairo UniversityNCT03717987Written as Botulinum toxin type A
- A Study to Evaluate the Tolerability of Botox and Topiramate or Botox and Placebo and Effect on Cognitive EfficiencyCompletedPhase 4Cady, Roger, M.D.NCT01700387Written as onabotulinumtoxinA
- Botulinum Toxin Type A Injection After Topical Anesthesia Versus Petrolatum OintmentCompletedPhase 4The University of Texas Health Science Center, HoustonNCT03799484Written as Botulinum toxin type A
- Integrated Management Enhances Functional Gains in Children With Cerebral Palsy Treated by BoNT-ACompletedPhase 3Kocaeli UniversityNCT03302871Written as Botulinum toxin type A
- Integrated Management of Pronation Deformity in Cerebral PalsyCompletedPhase 3Kocaeli UniversityNCT03472261Written as Botulinum toxin type A
Showing 20 of 36.
As the comparator · 39 — what is tested is compared with botulinum toxin type A
- A Study to Assess the Safety and Efficacy of Co-Reconstituted TrenibotulinumtoxinE and OnabotulinumtoxinA in Adult Participants With Moderate to Severe Upper Facial LinesRecruitingPhase 2AbbVieNCT07871513Written as OnabotulinumtoxinA
- To Evaluate HU-045 With Moderate to Severe Glabellar LinesRecruitingPhase 3Huons BiopharmaNCT07870694Written as Xeomin®
- Efficacy and Safety of Recombinant Botulinum Toxin Type A (Eveotox) for Injection to Treat Moderate to Severe Glabellar LinesRecruitingPhase 3JHM BioPharma (Tonghua) Co. , Ltd.NCT06937944Written as OnabotulinumtoxinA (Botox)
- Arthrocentesis Versus Botulinum Toxin Injection in Patients With Temporomandibular Joint Disorders: A Randomized Controlled TrialNot yet recruitingNot applicableMudher MB AlsunbuliNCT07736521Written as Botulinum Toxin-A
- A Clinical Study on Recombinant Botulinum Toxin Type A (YY001) for Injection in The Treatment of Upper Limb Spasticity in AdultsRecruitingPhase 2/3Chongqing Claruvis Pharmaceutical Co., Ltd.NCT06783114Written as BOTOX®
- Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar LinesNot yet recruitingPhase 3Daewoong Pharmaceutical Co. LTD.NCT07013279Written as Botox® 100 Units
- Efficacy of Nerve Block Versus Botox in Chronic Migraine ManagementRecruitingNot applicableZagazig UniversityNCT06684249Written as Botulinum Toxin A
- To Evaluate HU-045 in the Treatment of Glabellar Lines(Phase III)RecruitingPhase 3Huons BiopharmaNCT06205797Written as Xeomin®
- SURGERY VS BOTULINUM TOXIN ON QUALITY OF LIFE IN STROKE PATIENTS: RANDOMIZED TRIALRecruitingNot applicableFundación Pública Andaluza para la Investigación Biomédica Andalucía OrientalNCT06392633Written as Botulinum Toxin A
- A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial LinesActive, not recruitingPhase 1/2IpsenNCT04821089Written as Dysport
- A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)CompletedPhase 3Cutia Therapeutics(Wuxi)Co.,LtdNCT06585696Written as BOTOX®
- Evaluation of Three Types of Injection for the Treatment of Lateral EpicondylalgiaTerminatedNot applicableCentre Hospitalier Universitaire de NīmesNCT02325063Written as Botox injection
- A Phase I/II, Randomized, Double-blind, Placebo, and Active Controlled Clinical Study to Evaluate the Safety, Tolerability, Immunogenicity, and Preliminary Efficacy of JHM03 in Subjects With Moderate to Severe Glabellar LinesCompletedPhase 1/2JHM BioPharma (Tonghua) Co. , Ltd.NCT06199336Written as BOTOX®
- Double-blind Comparative Randomized MulticenterCompletedPhase 3Innopharm LLCNCT06840158Written as BOTOX®
- A Phase III Study to Evaluate the Efficacy and Safety of Recombinant Botulinum Toxin Type A for Injection in the Treatment of Moderate to Severe Glabellar LinesCompletedPhase 3Chongqing Claruvis Pharmaceutical Co., Ltd.NCT06499688Written as OnabotulinumtoxinA
- Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar LinesCompletedPhase 1Daewoong Pharmaceutical Co. LTD.NCT06212960Written as BOTOX®
- Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 TrialCompletedPhase 3CKD Bio CorporationNCT05804656Written as Botox®
- The Efficacy and Safety Study of Protoxin Versus Botox® in Subjects With Moderate to Severe Glabellar LinesCompletedPhase 3Protox Inc.NCT05364580Written as Botox®
- Phase 2 of HU-045 in Glabellar LinesCompletedPhase 2Huons Co., Ltd.NCT05298449Written as Xeomin®
- Safety and Efficacy of CKDB-501A in Subjects With Post-stroke Upper Limb SpasticityCompletedPhase 1CKD Bio CorporationNCT05382767Written as Botox®
Showing 20 of 39.
What changed recently
From the registry's own updates since Oct 18, 2026.
Results posted1
- A Study of NT 201 Doses in the Treatment of Platysma ProminenceNov 10, 2026NCT05773053
Stopped1
- Botox Injections in Non-Cranial Nerve VII Innervated Muscles for Facial SynkinesisWithdrawnNov 3, 2026NCT07295288
Newly registered4
- EndoFLIP-Guided Initial Management of Esophagogastric Junction Outflow ObstructionNov 10, 2026NCT07930143
- Evaluation of the Efficacy and Safety of Fractional CO₂ Laser With and Without Intradermal Botulinum Toxin A in the Treatment of Inflammatory Facial Acne Vulgaris.Nov 5, 2026NCT07919886
- Perineural Botulinum Toxin Injection Versus Oral Duloxetine in Relief of Foot Pain in Painful Peripheral Diabetic NeuropathyOct 20, 2026NCT07882238
- Cleft Lip Scarring After BotoxOct 19, 2026NCT07880860
Codes
What other systems call botulinum toxin type A · ClinicalTrials.gg INT008669
- MeSH (NLM) D019274Botulinum Toxins, Type AConfirmed ClinicalTrials.gov, Wikidata
- UNII (FDA) E211KPY694BOTULINUM TOXIN TYPE AConfirmed FDA, Wikidata
- RxNorm 1712Confirmed FDA, Wikidata
- Wikidata Q4095199botulinum toxin type AConfirmed FDA, Wikidata
- NCI Thesaurus C82623Botulinum Toxin Type AOne source FDA
- DrugBank DB00083One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D019274 | Botulinum Toxins, Type A | Confirmed ClinicalTrials.gov, Wikidata |
| UNII (FDA) | E211KPY694 | BOTULINUM TOXIN TYPE A | Confirmed FDA, Wikidata |
| RxNorm | 1712 | — | Confirmed FDA, Wikidata |
| Wikidata | Q4095199 | botulinum toxin type A | Confirmed FDA, Wikidata |
| NCI Thesaurus | C82623 | Botulinum Toxin Type A | One source FDA |
| DrugBank | DB00083 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.